text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 596-51-0 | Product Number: G0392


Purity: >98.0%(T)(HPLC)
  • 3-(2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidinium Bromide
1   ≥20 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).

Product Number G0392
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__9H__2__8BrNO__3 = 398.34  
Physical State (20 deg.C) Solid
Storage Temperature 0-10°C
Store Under Inert Gas Store under inert gas
Condition to Avoid Hygroscopic,Heat Sensitive
CAS RN 596-51-0
Reaxys Registry Number 3642926
PubChem Substance ID 253660366
Merck Index (14) 4501
MDL Number


Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Properties (reference)
Melting Point 195 °C
Solubility in water Soluble
Solubility (soluble in) Alcohol
Solubility (insoluble in) Ether
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Related Laws: / Compliance with laws, Regulations
Enzyme Commission 209-887-0
RTECS# UY4337630
Transport Information:
HS Number 2933998090
Glycopyrrolate (NVA237): A Long-Acting Muscarinic Receptor Antagonist (LAMA)

Glycopyrrolate (NVA237) is a synthetic anticholinergic agent and a long-acting muscarinic receptor antagonist (LAMA). It does not cross the blood–brain barrier and consequently has no or few central nervous effects. It has recently been approved as a once-daily treatment for chronic obstructive pulmonary disease (COPD). (The product is for research purpose only.)


PubMed Literature

Safety Data Sheet (SDS) Search
Please select Language.

The requested SDS is not available.

• Please check that the Product Number you have entered is correct.

• If your information is correct and you are still not able to view the requested SDS,  please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Other Documents